Table 3. Inhibition Zone (mm) and MIC (μg mL–1) of the Tested Compounds (14b, 14c, 14d, 18, 27a, and 27b) in the case of Antifungal Activity.
| sample
no. |
|||||||
|---|---|---|---|---|---|---|---|
| fungal strains | 14b | 14c | 14d | 18 | 27a | 27b | refa |
| C. albicans | 12b(8.0)c | 13(9.0) | 18(7.0) | 13(8.0) | 13(7.0) | 14(8.0) | 20(5.0) |
| T. rubrum | 10(11) | 19(10) | 26(8.0) | 12(9.0) | 10(9.0) | 13(8.0) | 36(5.0) |
| A. flavus | 18(8.0) | 24(8.0) | 25(9.0) | 20(10) | 23(9.0) | 10(9.0) | 44(6.0) |
| F. oxysporum | 15(9.0) | 17(8.0) | 18(8.0) | 16(7.0) | 15(9.0) | 16(7.0) | 28(4.0) |
| S. brevicaulis | 10(11) | 15(9.0) | 16(8.0) | 13(9.0) | 10(10) | 13(10) | 20(5.0) |
| G. candidum | 13(10) | 16(8.0) | 17(9.0) | 14(8.0) | 11(8.0) | 13(8.0) | 24(5.0) |
a
Ref = clotrimazole as antifungal reference; amount added to each pore = 50 μL.
b
The diameter of inhibition zone in (mm) of compounds (14b, 14c, 14d, 18, 27a, and 27b).
c
MIC (minimum inhibition concentration) in (μg mL–1) of compounds (14b, 14c, 14d, 18, 27a, and 27b).